✦ LIBER ✦

Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen

✍ Scribed by Casey, S.; Treleaven, J.; Powles, T.J.; O'Brien, M.E.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Practice Guidelines for the man

✍ C. Mark Taylor; Sam Machin; Stephen J. Wigmore; Tim H. J. Goodship; on behalf of 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 921 KB

Prognostic significance of certain facto

✍ M. Sieniawska; J. Korniszewska; C. Gura; J. Welc-Dobies; Z. Lewicki 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 635 KB

The oxidative stress induced in vivo by

✍ Gomez, S. A.; Abrey-Recalde, M. J.; Panek, C. A.; Ferrarotti, N. F.; Repetto, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 842 KB

The expression of blood group P1 in post

✍ C. Mark Taylor; David V. Milford; Peter E. Rose; Tom C. F. Roy; Bernard Rowe 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 310 KB

RECURRENCE OF HAEMOLYTIC URAEMIC SYNDROM

✍ Leithner, C.; Sinzinger, H.; Pohanka, E.; Schwarz, M.; Kretschmer, G.; Syre, G. 📂 Article 📅 1982 🏛 The Lancet 🌐 English ⚖ 144 KB

Decrease of thrombomodulin contributes t

✍ Julie M. Williams; C. Mark Taylor 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 103 KB